Latest Astrazeneca Pharma India Ltd (ASTRAZEN:NSI) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
A company profile report for AstraZeneca Pharma India Limited (AZPIL) from publisher Life Science Analytics Inc. is presented, with topics including management profile, company announcements, deals, alliances and product updates.EBSCO_bspAstrazeneca Pharma India Limited Medtrack Company Profile...
以计算AstraZeneca Pharma India的保险结算为例,见下文:计算示例 行业基准分析 板块 上图描述了发展中经济区的板块医疗保健公司保险结算的分布情况。我们分析了超过40家公司,其中45家的数据为有效数据。这些板块公司的平均保险结算为22.85 M,标准差为39.589 M。 AstraZeneca Pharma India的保险结算排名为第-名,处于...
AstraZeneca Pharma India Limited has received import and market permission in Form CT-20 from the Drugs Controller General of India for selumetinib 10 mg & 25 mg capsule. Selumetinib 10 mg & 25 mg capsule is indicated for treatment of paediatric patients 3 years of age and older with ...
AstraZeneca Pharma India的现价与52周高点的百分比值是79.4%. 查看AstraZeneca Pharma India的现价与52周高点的百分比值趋势、图表等
ASTRAZEN: AstraZeneca Pharma India Ltd. AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells ...+ VIEW MORE ...
AstraZeneca India, a leading science-led biopharmaceutical company, and the Banaras Hindu University (BHU) conducted a cancer screening camp for women in Varanasi. This is the second such camp set up in and around Varanasi, as a part of the Ganga Godavari Cancer Screening programme, since the...
2Hoventa Pharma 1Luna Chemicals 1Vio Chemicals 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. ResetOK CAS Number ResetOK Country ResetOK 01 CTX Lifesciences India Post Enquiry Medlab Asia & Asia Health Not Confirmed Post Enquiry 02
Last week, AstraZeneca (London) signed a license and supply agreement with the drug company and manufacturer Torrent Pharmaceuticals (Ahmedabad, Gujarat, India), under which Torrent will supply to AstraZeneca a portfolio of generic medicines for emerging markets. This agreement...
dated September 14, 2011 pursuant to Section 302 of the Act, setting out the material terms of Mr. Anandh's re-appointment and remuneration provided in the Agreement dated September 14, 2011, was sent to the Members.Pawan Singhal